Description

Product information

IUPAC-name  4-chloro-2,5-dimethoxy-a-methyl-benzeneethanamine, monohydrochloride

Synonyms     2,5-dimethoxy-4-chloroamphetamine, DOC

Formal name   4-chloro-2,5-dimethoxy-a-methyl-benzeneethanamine, monohydrochloride

Cas number   42203-77-0

Formula    C₁₁H₁₆ClNO₂ • HCl

Formula Weight   266.2

Purity     99.0 % min.

Formulations    A neat solid, Powder

2,5-dimethoxy-4-chloroamphetamine, DOC

Commonly referred to as DOC or 4-Chloro-2,5-dimethoxyamphetamine, this substance is a member of the so-called “DOx” family of amphetamines that have long-lasting effects and are known for their stimulant and psychedelic properties.

The first known production of DOC was carried out in 1972. It wasn’t widely used in humans until Alexander Shulgin’s 1991 book PiHKAL, which provided a glimpse into the use of this substance in people. In 1989, a forensic analysis of seized designer amphetamines identified DOC as one of the drugs.

It’s commonly sold in powder or on paper, and it has a long-lasting effect that can last up to 24 hours. Its unique psychoactive properties include a distinct form of stimulation and a large body load.

Due to its unusual long-lasting effects and its sensitive dose-response, it has been reported that people who are not used to using hallucinogenic drugs might find it difficult to use safely. This is why it’s important to follow proper harm reduction and precaution steps when using this substance.

History

The precursor of amphetamines, known as DOC, was first synthesized in 1972 by Jerry Malicky and Ronald Coutts at the University of Alberta. It was identified as a designer drug in Canadian drug seizures in 1989.

Chemistry

4-chloro-2,5-diethyl-amphetamine, also known as DOC, is a amphetamine analogue. It is produced by the substitution of phenethylamines with a phenyl ring bound to an amino acid. These compounds are then bound to a methyl group. The resulting compounds have various functional groups, such as OCH3.

Phenethylamines are commonly used as amphetamines. The equivalent of this substance, which is 2C-C, is called DOC. It has a stereocenter and is more active than the other analogues.

Pharmacology

The drug DOC is a partial agonist of the 5-HT2A receptor, and its psychedelic effects are mediated by its actions on the other receptors.

It’s believed that the drug’s psychedelic effects are caused by its ability to activate the 5-HT2A receptor. However, the exact mechanisms by which this effect is achieved remain unclear.

The toxicological and physiological properties of this compound has not been analyzed. Usage of this Chemical should be for research and forensic purposes only.

WARNING This product is not for human or veterinary use.

This product is only available to persons of 21 years old and above.

Hazard statement(s)